Atlas Trials

MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer

Clinical trial NCT03461354 · TERMINATED

Trial details

NCT number
NCT03461354
Sponsor
Wake Forest University Health Sciences
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Mucositis OralHead and Neck Cancer
Start date
2018-04-09
Primary completion
2024-04-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.